• Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2020

  • Collaborator: Dermatology Center, GEM Resopso, University Sorbonne Paris Nord

  • Authors: Halioua B, Zetlaoui J, Astruc A, Lévy-Heidmann T, Testa D, Bombezin-Domino A, Radoszycki L

Patients with chronic medical conditions (CMC) require regular access to healthcare professionals and have to take long-term treatments. The coronavirus (COVID-19) may affect their clinical outcomes.